Ramadan fasting safety for adrenal insufficiency
Part of Heart & circulation, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at whether it is safe for people with primary adrenal insufficiency to fast during Ramadan, and checks for any risks. It is for those who are already on stable replacement treatment and want to fast in 2026.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary adrenal insufficiency (your adrenal glands do not produce enough hormones) for at least one year.
- You are taking both a glucocorticoid (like prednisolone) and a mineralocorticoid (like fludrocortisone) as replacement therapy.
- You plan to fast during Ramadan 2026.
- You do not have diabetes, kidney, liver, heart, or lung disease.
- You are not taking certain medicines like sulfonylureas (for diabetes) or diuretics (water pills), and you are not using any extra glucocorticoids beyond your usual replacement.
- You are not pregnant, breastfeeding, or menstruating at the time of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how fasting during Ramadan affects people with secondary adrenal insufficiency (a condition where the body doesn't produce enough cortisol). It compares your blood pressure symptoms before and after a treatment for low blood pressure, to see if the treatment helps you fast safely.
This study looks at how people with type 2 diabetes experience fasting during Ramadan. By joining, you'll help researchers understand the challenges and benefits of fasting with diabetes.
This study looks at how fasting during Ramadan affects children with type 1 diabetes. It compares children who fast with those who don't, to see how blood sugar and health are impacted.
This study compares two types of fasting—Ramadan dry fasting and 16:8 time-restricted eating—to see how they affect your cells' energy and health. It may help you understand which fasting style is better for your body.
This study tests an oral medication called orforglipron to see if it safely helps people with type 2 diabetes manage their blood sugar while they fast during Ramadan. You may be a good fit if you are planning to fast and your diabetes is not too severe.
This trial tests three different fasting schedules to see which one best improves blood sugar, inflammation, and body composition in people with prediabetes. You'll be randomly assigned to one of the fasting plans and follow it for 4 to 6 weeks.
Hear when a new Continuous Glucose Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.